Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Duffaud

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2023
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 yearsJ Y Blay, C Tlemsani, M Toulmonde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2019
Surgery in reference centers improves survival of sarcoma patients: a nationwide studyJ-Y Blay, C Honoré, E Stoeckle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2024
Improved nationwide survival of sarcoma patients with a network of reference centersJ Y Blay, N Penel, T Valentin, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2023
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 yearsJ Y Blay, C Tlemsani, M Toulmonde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2019
Surgery in reference centers improves survival of sarcoma patients: a nationwide studyJ-Y Blay, C Honoré, E Stoeckle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2024
Improved nationwide survival of sarcoma patients with a network of reference centersJ Y Blay, N Penel, T Valentin, et al.
Pageof 8